3. PE: BT 37 oC, BP 110/70 mmHg, RR 22/min,
PR 118/min
Mark pale, mild icteric sclera
Liver 6 cm below RCM, spleen 5 cm below LCM
Investigation:
Hb 2.5 g/dL, HCT 10.6 %, WBC 5350/cu.mm.,
platelet 154,000/cu.mm.N 80 %, band 3 %, L 16 %,
Reticulocyte count 14.72 %
MCV 87.6, MCH 20.7, MCHC 23.6, RDW 37.3
4.
5.
6.
7.
8. Chol 104, alb 4, glob 3.5, TB 4.5, DB 0.7, ALT 23,
AST 28, AP 64
Hb typing EABart’sH [E 10%, F 0.7%]
Direct Coombs test – positive 3+
Indirect Coombs test – positive 4 +
Identify alloantibody – anti E
10. Day1
start dexamethasone 5 mg IV q 6 h
LPB 2 unit IV Hct 10 →18%
Day2
LPB 2 unit IV Hct 18 → 21 %
Day 5
Hct 21%
prednisolone 4 x 3
TreatmentTreatment
11. Day 30
CBC: Hb 8.6 g/dL, Hct 29.5%, WBC 9500/cu.mm
plt 290,000/cu.mm, N 76.5
prednisolone 5 x 2 /2 wks
4 x 2 /2 wks
TreatmentTreatment
12. Classification of immune hemolytic anemiaClassification of immune hemolytic anemia
• Autoimmune hemolytic anemia
– Warm AIHA
– Cold agglutinin diseases
– Mixed type AIHA
– Proxysmal cold hemoglobinuria
• Alloimmune hemolytic anemia
– Hemolytic transfusion reaction
– Hemolytic disease of new born
• Drug-induced immune hemolytic anemia
– Drug-adsorption
– Drug-immune complex
– Autoantibody type
20. Red blood cell transfusionRed blood cell transfusion
Least incompatible blood
21. Red blood cell transfusionRed blood cell transfusion
Patient should be tested for co-existing alloantibodies
(15-40 %)
Alloantibodies > autoantibodies cause major
transfusion reaction
Most patients tolerate even serologically incompatible
blood
Patient with symptoms of severe anemia